Filing Details
- Accession Number:
- 0001214659-23-013141
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-04 16:30:18
- Reporting Period:
- 2023-10-02
- Accepted Time:
- 2023-10-04 16:30:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
791908 | Xoma Corp | XOMA | Pharmaceutical Preparations (2834) | 522154066 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1575933 | Owen Hughes | C/O Xoma Corporation 2200 Powell Street, Suite 310 Emeryville CA 94608 | Exec Chairman And Interim Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-10-02 | 1,000 | $13.83 | 3,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Depositary Shares - 8.375% B Cumulative Stock | 2,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.80 to $13.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.